Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL – Get Free Report) saw a large increase in short interest in the month of December. As of December 31st, there was short interest totaling 321,082 shares, an increase of 6,821.4% from the December 15th total of 4,639 shares. Based on an average trading volume of 2,087,927 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.9% of the shares of the company are short sold. Approximately 0.9% of the shares of the company are short sold. Based on an average trading volume of 2,087,927 shares, the days-to-cover ratio is presently 0.2 days.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Adlai Nortye in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Reduce”.
Check Out Our Latest Stock Report on ANL
Adlai Nortye Trading Up 3.8%
About Adlai Nortye
Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.
Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.
The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.
Featured Articles
- Five stocks we like better than Adlai Nortye
- “Ominous day” coming to stocks…
- Punch these codes into your ordinary brokerage account
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Trump just signed it
- A month before the crash
Receive News & Ratings for Adlai Nortye Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adlai Nortye and related companies with MarketBeat.com's FREE daily email newsletter.
